Derivative | Functional group | Synthesis condition | Anti-Scale performance | Ref. |
---|
Polyaspartic acid/4‐ (2‐amin-oethyl) morpholine graft copolymer (PASP/AEM) | —C—O—C—,—COOH | m (PSI):m (AEM)=1:1.05 | When the dosage of PASP/AEM is 10.0 mg/L, anti Ca3(PO4)2 scale rate is 100%, when C (PASP/AEM) =56.0 mg/L, the transmittance of Fe2O3 is 66% | [15] | ESA/AMPS | —C(=O)—NH | | When the dosage of ESA/AMPS is 35 mg/L, anti Ca3(PO4)2 scale rate is 100%, and the transmittance of Fe2O3 is 57% | [16] | Polyaspartic acid derivative(PASPTU) | —OH,—CONH2 | PSI:threonine:urea=1:0.2:0.8 | When the dosage of PASPTU is 8 mg/L, anti Ca3(PO4)2 scale rate is 100% | [17] | PASP/Urea | —CONH2,—NH2 | | Anti CaCO3 scale rate is 90%, anti Ca3(PO4)2 scale rate is 90%, and anti CaSO4 scale rate is 97% | [18] | L-cysteine modified polyepoxysuccinic acid (LCY-PESA) | —SH,—CONH2 | m (PESA):m (LCY) =10:1 | When the dosage of LCY-PES is 6 mg/L, anti-scale rate is 94.6%, and the transmittance of Fe2O3 is 61.5%, which is lower than PESA about 20%. At the same time, LCY-PESA has excellent biodegradability | [19] |
|